Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$694,526
+$45,319 QoQ
Shares Held
2,760
-7.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,878
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLORIDA FINANCIAL ADVISORS, LLC holds $11,844,301 across 8 Drug Manufacturers - General names. ABBV ranks #3 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
31,192 | $7,921,832 | |
| 2 | LLY |
ELI LILLY & Co
|
1,444 | $1,731,977 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
2,760 | $694,526 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,403 | $565,785 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,351 | $297,025 | |
| 6 | AMGN |
Amgen Inc
|
600 | $217,272 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,617 | $208,411 | |
| 8 | PFE |
Pfizer Inc
|
8,616 | $207,473 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $694,526 | 2,760 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $649,207 | 2,985 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $648,454 | 2,838 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $501,284 | 2,165 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $629,251 | 3,390 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $580,998 | 2,773 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $527,946 | 2,971 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $394,960 | 2,000 | Shares | Sole | 2025-01-10 | |
| 2024-06-30 | $294,499 | 1,717 | Shares | Sole | 2025-01-10 | |
| 2024-03-31 | $277,156 | 1,522 | Shares | Sole | 2025-01-10 | |
| 2023-12-31 | $258,334 | 1,667 | Shares | Sole | 2025-01-10 | |
| No filing history on record for this holder in this stock. | ||||||